IAN Funded Clinical Research Co. Karmic Lifesciences Acquired By Cliantha Research
July 31, 2014 2014-07-31 9:26IAN Funded Clinical Research Co. Karmic Lifesciences Acquired By Cliantha Research
IAN Funded Clinical Research Co. Karmic Lifesciences Acquired By Cliantha Research
Cliantha Research, Ahmedabad headquartered global lifesciences company has acquired Karmic Lifesciences, Contract Research Organization headquartered in Mumbai, India.
Started in 2005, Karmic Lifesciences has executed 150+ Clinical Trials and 75+ Clinical Data Management & Bio-Statistics Projects (Phase I to IV) in various therapeutic areas including Oncology, Cardiovascular, Diabetes, Neurology, Auto-Immune Diseases, Ophthalmology, and Medical Devices. Karmic recently has successfully launched medico-marketing services for the pharmaceutical industry.
Karmic Lifesciences has developed kTrials™, a proprietary 21 CFR Part 11, CDASH/CDISC and SDTM Compliant, Web-Enabled eClinical Suite with integrated Clinical Trial Management, Clinical Data Management, eTMF, IWRS, SDTM Mapping, Clinical Data Warehousing and Operational Analytics functionalities designed especially to support Karmic’s end-to-end Global Clinical Operations, Data Management and Project Management requirements.
The system supports end-to-end operational activities right from project set-up, planning, budgeting, execution, performance analytics and reporting for all clinical trials conducted by Karmic apart from storing all clinical and operational enterprise data as well as electronic trial master files in a single repository.
#ShortNews: News you could use, useful data and actionable insights in a crisp and easy format. (Feedback:team@nextbigwhat.com)